Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback